Patents by Inventor Zhikun NI

Zhikun NI has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • HETEROCYCLIC COMPOUNDS
    Publication number: 20240327417
    Abstract: Disclosed herein is a compound of Formula (I) having the following structure for activating T cells, promoting T cell proliferation, and/or exhibiting antitumor activity, a method of using the compounds disclosed herein for treating cancer, and a pharmaceutical composition comprising the same.
    Type: Application
    Filed: June 4, 2024
    Publication date: October 3, 2024
    Applicant: Beigene Switzerland GMBH
    Inventors: Guoliang Zhang, Zhikun Ni, Jianzhuang Miao, Ce Wang
  • Pyrazolopyridinone Compounds
    Publication number: 20240300951
    Abstract: Disclosed herein is a compound of Formula (I) for activating T cells, promoting T cell proliferation, and/or exhibiting antitumor activity, a method of using the compounds disclosed herein for treating cancer, and a pharmaceutical composition comprising the same.
    Type: Application
    Filed: February 2, 2024
    Publication date: September 12, 2024
    Applicants: BeiGene Ltd., Beigene Switzerland GMBH
    Inventors: Guoliang Zhang, Zhikun Ni, Jianzhuang Miao, Ce Wang
  • Pyrazolopyridinone Compounds
    Publication number: 20240270751
    Abstract: Disclosed herein is a compound of Formula (I) for activating T cells, promoting T cell proliferation, and/or exhibiting antitumor activity, a method of using the compounds disclosed herein for treating cancer, and a pharmaceutical composition comprising the same.
    Type: Application
    Filed: March 13, 2024
    Publication date: August 15, 2024
    Applicants: BeiGene Ltd., Beigene Switzerland GMBH
    Inventors: Guoliang Zhang, Zhikun Ni, Jianzhuang Miao, Ce Wang
  • KRAS G12C INHIBITORS
    Publication number: 20240166660
    Abstract: Disclosed herein are compounds or a stereoisomer thereof, or a pharmaceutically acceptable salt thereof useful as G12C inhibitors, and a pharmaceutical composition comprising the same.
    Type: Application
    Filed: January 14, 2022
    Publication date: May 23, 2024
    Inventors: Guoliang ZHANG, Jianzhuang MIAO, Ce WANG, Zhikun NI, Huaguo LI